Aquanaz Tablet
Product Images NDC 29978-587

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Aquanaz (NDC 29978-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Capital Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 29978-587-01newaquanaztabletstriple Combination Relief:cough Suppressant: Dextromethorphan Hbr 15 mgexpectorant: Guaifenesin 400 mgdecongestant: Phenylephrine HCl 10 mg100 Tablets (Aquanaz Tablets 01)

Aquanaz tablets label showing a human OTC drug with a triple combination relief formula containing Dextromethorphan HBr 15 mg (cough suppressant), Guaifenesin 400 mg (expectorant), and Phenylephrine HCl 10 mg (nasal decongestant). The package contains 100 tablets and is distributed by Capital Pharmaceuticals, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.